We are live on
!
Find out more
Thrivent Financial for Lutherans Portfolio holdings
AUM
$52.5B
1-Year Est. Return
27.12%
This Fund
S&P 500
This Quarter
Est. Return
+3.89%
1 Year Est. Return
+27.12%
3 Year Est. Return
+79.38%
5 Year Est. Return
+100.59%
10 Year Est. Return
+446.21%
AUM
$24.1B
AUM Growth
+$998M
(+4.3%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
15.36%
Holding
2,169
New
153
Increased
1,269
Reduced
465
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$230M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$157M |
| 3 |
Starbucks
SBUX
|
+$94.7M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$84.5M |
| 5 |
HOLX
Hologic
HOLX
|
+$79.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$139M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$122M |
| 3 |
AGN
Allergan plc
AGN
|
+$121M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$120M |
| 5 |
Gilead Sciences
GILD
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.77% |
| 2 | Technology | 12.64% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11.95% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Nasdaq
NDAQ
$52.7B
| $310K | ﹤0.01% |
12,990
+300
| +2% | +$6.9K |
|
1677
NiSource
NI
$21.3B
| $310K | ﹤0.01% |
12,209
+250
| +2% | +$6.23K |
|
1678
VeriSign
VRSN
$26.2B
| $310K | ﹤0.01% |
3,340
+80
| +2% | +$7.22K |
|
|
VRTV
1679
DELISTED
VERITIV CORPORATION
VRTV
| $309K | ﹤0.01% |
6,860
+260
| +4% | +$11.9K |
|
1680
Sonic Automotive
SAH
$2.9B
| $308K | ﹤0.01% |
15,850
+890
| +6% | +$17K |
|
1681
Qorvo
QRVO
$7.99B
| $306K | ﹤0.01% |
4,840
-8,960
| -65% | -$641K |
|
1682
Buckle
BKE
$2.25B
| $305K | ﹤0.01% |
17,120
+970
| +6% | +$17.3K |
|
1683
Knowles
KN
$3.13B
| $305K | ﹤0.01% |
18,030
+1,370
| +8% | +$24.6K |
|
|
LDR
1684
DELISTED
Landauer Inc
LDR
| $305K | ﹤0.01% |
5,830
+320
| +6% | +$16.5K |
|
|
CARO
1685
DELISTED
Carolina Financial Corp.
CARO
| $304K | ﹤0.01% |
+9,391
| New | +$288K |
|
1686
Enanta Pharmaceuticals
ENTA
$366M
| $303K | ﹤0.01% |
8,410
+570
| +7% | +$18.2K |
|
1687
The Mosaic Company
MOS
$7.03B
| $302K | ﹤0.01% |
13,220
-1,230,600
| -99% | -$30.2M |
|
|
EGL
1688
DELISTED
Engility Holdings, Inc.
EGL
| $302K | ﹤0.01% |
10,622
+650
| +7% | +$18.1K |
|
1689
ArcBest
ARCB
$3.23B
| $298K | ﹤0.01% |
14,480
+870
| +6% | +$18.9K |
|
1690
Allegion
ALLE
$13.4B
| $294K | ﹤0.01% |
3,621
+120
| +3% | +$9.4K |
|
1691
FTI Consulting
FCN
$4.4B
| $293K | ﹤0.01% |
8,380
+580
| +7% | +$21.2K |
|
|
AMRI
1692
DELISTED
Albany Molecular Research Inc
AMRI
| $292K | ﹤0.01% |
13,460
+820
| +6% | +$14.9K |
|
1693
Greif
GEF
$4.92B
| $291K | ﹤0.01% |
5,220
+350
| +7% | +$19.8K |
|
1694
Flotek Industries
FTK
$852M
| $290K | ﹤0.01% |
5,402
+225
| +4% | +$14.2K |
|
1695
iShares Global Healthcare ETF
IXJ
$4.07B
| $290K | ﹤0.01% |
5,342
-1,142
| -18% | -$60.7K |
|
1696
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
| $290K | ﹤0.01% |
+27,925
| New | +$284K |
|
1697
Century Casinos
CNTY
$34M
| $288K | ﹤0.01% |
+39,021
| New | +$306K |
|
1698
MarineMax
HZO
$759M
| $288K | ﹤0.01% |
14,750
+920
| +7% | +$18K |
|
|
PGNX
1699
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $288K | ﹤0.01% |
42,380
+2,710
| +7% | +$20K |
|
1700
BlackRock Taxable Municipal Bond Trust
BBN
$978M
| $286K | ﹤0.01% |
+12,475
| New | +$284K |
|
Similar funds
SCP
Thrivent Financial for Lutherans's Q2 2017 Portfolio in Review
As of Q2 2017, Thrivent Financial for Lutherans held 2,169 positions worth $24.1B, up 4.3% from $23.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Thrivent Financial for Lutherans's Q2 2017 filing shows 153 new, 1,269 increased, 465 reduced and 139 closed positions. Its largest new stake was Ally Financial: 2,600,286 shares worth $54.3M. The largest sale was Walgreens Boots Alliance, an estimated $139M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
- Thrivent Financial for Lutherans's largest Q2 2017 buy was Ally Financial: 2,600,286 shares worth $54.3M.
- Thrivent Financial for Lutherans added most to UnitedHealth in Q2 2017, an estimated $230M increase.
- Thrivent Financial for Lutherans's biggest Q2 2017 reduction was Walgreens Boots Alliance, cutting an estimated $139M.
- Thrivent Financial for Lutherans fully exited Paycom in Q2 2017, selling an estimated $38.5M.
- Thrivent Financial for Lutherans's ten largest holdings make up 15% of its $24.1B portfolio in Q2 2017.
- Thrivent Financial for Lutherans opened 153 new positions and closed 139 in Q2 2017.
- Thrivent Financial for Lutherans's portfolio value rose 4.3% quarter-over-quarter to $24.1B.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2017, filed 11 Aug 2017.